Stock Events

Stock Events

PAVmed 

0
41
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q1 2026
Q2 2026
Next
-3.8
-2.67
-1.54
-0.41
Expected EPS
-0.5079781999999999
Actual EPS
N/A

Financials

-3,092.01%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
61,063.65Revenue
-1.89MNet Income

Analyst Ratings

43.25Average Price Target
The highest estimate is 43.25.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1P5.STU. It's not an investment recommendation.
Apple
10
AAPL
Microsoft
10
MSFT
Tesla
10
TSLA
Alphabet
10
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation competes with PAVmed in the medical devices sector, particularly in areas such as cardiovascular and endoscopy products.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc is a direct competitor in the medical devices industry, offering products in areas like cardiac and vascular, which overlaps with PAVmed's portfolio.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories competes with PAVmed through its range of medical devices, including cardiovascular and diabetes care products.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgery and orthopaedics, relevant to PAVmed's market.
Smith & Nephew
SNN
Mkt Cap12.08B
Smith & Nephew plc offers medical devices in orthopaedics, sports medicine, and wound management, competing with PAVmed's surgical and medical device products.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation is a competitor in the medical technology field, with products in orthopaedics, surgery, and neurotechnology that compete with PAVmed's offerings.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. competes with PAVmed in the orthopaedic device sector, offering products for joint reconstruction which is a potential area of competition.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences Corporation is a competitor in the cardiovascular device market, directly competing with some of PAVmed's cardiovascular products.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, Inc. competes with PAVmed in the surgical devices market, particularly with its robotic-assisted surgical systems.
Baxter International
BAX
Mkt Cap13.35B
Baxter International Inc. competes with PAVmed in the medical devices and hospital products sector, including areas like renal care and advanced surgery.

About

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
Show more...
CEO
Lishan Aklog
Employees
41
Country
United States
ISIN
US70387R5028
WKN
000A41RVK

Listings

STU
DE
1P5.STU
F
DE
1P5.F
XNAS
US
PAVM
BOATS
BOATS
PAVM.BOATS

0 Comments

Share your thoughts

FAQ

What is PAVmed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange PAVmed stocks are traded under the ticker 1P5.STU.
When is the next PAVmed earnings date?▼
PAVmed is going to release the next earnings report on November 17, 2026.
What were PAVmed earnings last quarter?▼
1P5.STU earnings for the last quarter are -0.75 EUR per share, whereas the estimation was -0.41 EUR resulting in a -85.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is PAVmed revenue for the last year?▼
PAVmed revenue for the last year amounts to 61,063.65 EUR.
What is PAVmed net income for the last year?▼
1P5.STU net income for the last year is -1.89M EUR.
How many employees does PAVmed have?▼
As of September 08, 2026, the company has 41 employees.
In which sector is PAVmed located?▼
PAVmed operates in the Health & Wellness sector.
When did PAVmed complete a stock split?▼
The last stock split for PAVmed was on January 02, 2026 with a ratio of 1:30.
Where is PAVmed headquartered?▼
PAVmed is headquartered in NEW YORK, United States.